For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Tokyo 2020: A very different Olympics with value not to be overlooked
Tokyo 2020: A very different Olympics with value not to be overlooked

Sports physician Chris Milne discusses the Olympic Games, due to begin next month, and what will be expected of our athletes to help keep everyone safe
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Hamilton B, Anderson L, Anglem N, et al. Medical considerations for supporting elite athletes during the post-peak phase of the New Zealand COVID-19 pandemic: a New Zealand sporting code consensus. N Z Med J 2020;133(1517):107–16.
2. Hughes D, Saw R, Perera NKP, et al. The Australian Institute of Sport framework for rebooting sport in a COVID-19 environment. J Sci Med Sport 2020;23(7):639–63.
3. Shimizu K, Sridhar D, Taniguchi K, et al. Reconsider this summer's Olympic and Paralympic games. BMJ 2021;373:n962.